Report Categories
View AllRecent Articles
View All
HALO Halozyme Therapeutics reports 375 revenue growth in Q1 but shares decline 175 despite beat
UNCY Unicycive Therapeutics reports wide Q4 2025 EPS miss shares dip slightly amid soft investor sentiment
What Wall Street expects from Eco Wave WAVE this quarter Eco Wave beats EPS by 193 posts narrower Q4 loss
What Bicara BCAX management said that matters most Bicara posts small EPS beat no Q4 revenue logged